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in combination (62% vs 54%, respectively). The safety of 4GCs also 
seems similar to other cephalosporins: in reviews of 3103 patients 
treated with cefpirome and 2032 mated with cefepime, adverse 
events were recorded in 22% and 20.3% of patients, respectively. 
The most commonly-reported AEs are headache, nausea, diarrhea 
and vomiting. It is concluded that 4GCs are suitable agents for the 
treatment of severe n o s o c o d  infections, and show promise for the 
treatment of meningitis and paediatric infections. 
Evidence-based choice of antibiotic therapy in 
ambulatory practice 
The importance of clinical microbiology in 
ambulatory practice 
L.B. Reller. Duke University Medical Center, Durham, North Carolina, 
USA 
Objectives: To apply evidenced-based clinical microbiology to the 
management of upper and lower respiratory tract infections. 
Methods: By asking focused questions both practitioners as well as 
microbiologists can enhance the clinical value of microbiological tests 
for respiratory tract mfections. Why is the test being done? What re- 
sults can be expected? Will they be used to start ,  stop, or change ther- 
apy? Is there a simpler (and cheaper) approach? What are the implica- 
tions of not doing the test? What are the pitfaus of empirical therapy? 
Results: Most causes of nonexudative and exudative pharyngi- 
tis (adenovirus and Epstein-Barr virus) are viral. Cultures for group 
A smptococci are imperative if direct antigen tests are negative or 
if susceptibdxty testing is required owing to failures with antibiotics 
other than ,%lactams. Cultures rarely are required for acute otitis me- 
dia or sinusitis; complicated and chronic infections necessitate tym- 
panocentesis or direct aspirates. Cultures are not indicated for acute 
exacerbations of chronic bronchitis. To query pneumonias, sputum 
samples should be screened for quality (presence of neutrophils and 
absence of squamous epithelial cells) unless legionellosis or tuber- 
culosis is suspected. The gram-stained smear may suffice unless 
gram-negative bacilli and purulence are seen or penicillin-resistant 
pneumococci are sought. Cultures without Gram s t a i n s  defy inter- 
pretation. Many “atypical” pneumonias, includmg mycoplasma and 
chlamydia, are not routinely confirmed by laboratory testing. 
Conclusions: Microbiological investigations can be increased in 
value by asking appropriate questions and submitting only relevant 
specimens. 
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1s85) Molecular Biology of Prion Diseases 
C. Weissmann, A. Raeber, M. Fischer, A. Sailer, T. Riilicke’ ‘ Biologisches Zentrallabor, Univmitiitsspital Zurich, Switzerland 
The prion, the transmissible agent that causes mad cow disease and 
scrapie, is believed to be PrP*, a misfolded form of a normal host 
protein, PrPc, whch is found mainly in the central nervous system, 
but also in many other organs. PrPc is encoded by a single copy 
gene called plnp. The ‘)rolein only” hypothesis proposes that PrP’ 
propagates by causing conversion of PrPc into PrP’. We generated 
mice devoid of PrPc (“Prnp”” “) mice and found them to be totally 
resistant to scrapie and incapable of propagating prions. Introduction 
of PrP transgenes restored susceptibility to scrapie, paving the way to 
reverse genetics. We have prepared axumals transgenic for PrP genes 
with diverse mutations and determined which part ofthe molecule is 
important for susceptibility to scraspie. We have also introducing PrP 
genes controlled by promotors leading to overexpression in various 
tissues and have determined that expression of PrP in T cells is insuf- 
ficient to allow prion propagation, while expression in splenocytes is 
permissive, suggesting that other components may be required. Re- 
garding practical applications, we expect that cattle or sheep devoid 
of PrP genes should be resistant to scrapie; the knockout technology 
is however not yet available for cattle. 
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Trends in nosocomial infections in Europe 
(ESCMID Study Group on Nosocomial 
Infections) 
Is86/ Epidemiology of Nosocomial Infections in 
Europe: Can We Better? 
C. Ruef. University Hospital qfzurich, Zurich, Switzerland 
Nosocomial infections (NI )  are a burden to the health care systems of 
all European countries and often pose sigdicant problem for local 
providers of care. However, not irhequently, patients colonized or 
infected with nosocomial pathogens are transferred between coun- 
tries or regions. Therefore, the way NI are controlled, prevented 
or treated in one country m y  have consequences for the care of 
patients in other countries. 
Improved knowledge of the epidemiology of NI in Europe is 
needed in order to a) anticipate potential problems, i.e. associated 
with transfer of patients who are colonized or infected with muleire- 
sistant organisms; b) monitor the incidence and prevalence of noso- 
comial mfections; c) detect the epidemic spread of relevant pathogens 
(i.e. MRSA, penicillin-resistant pneumococci); d) locally improve the 
practice ofmfection control and infectious diseases by adapting meth- 
ods oflocal practice to procedures which have been shown to be suc- 
cessful in other countries. Sound and uniformly applied epldemiolog- 
ical methods are needed in order to obtain meaningful data on inci- 
dence and prevalence of nosocomial infections in various European 
countries. It wdl be necessary to coordmate national efforts on an in- 
ternauonal level. Such cooperations will likely be fi-uidul and result in 
a better acceptance of hospital epidemiology as a pro-active specialty 
which goes beyond the simple tabulation of infection rates. Such a 
pro-active approach will contribute to the continuous improvement 
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of quality in health care delivery through increased and data-driven 
preventive efforts. Applied epidemiological and &cal research to- 
gether with teaching of health care workers are key components of 
this strategy. If European hospital epidemiologists and infectious dis- 
eases specialists join forces in this field, we can indeed do better. 
Trends in nosocomial infections in Europe: 
Comparison between Westem and Central 
Europe 
V &&dry, Jr.. University of Enaua, Dept. ofMedicine Slovak 
Republic, Slovakia 
In 1970-1990 in Western Europe expansion of medical technology 
was marked. In addition, medium age in Western Europe and Scan- 
dinavia increased. This both caused an marked increase of number of 
hospitalized patients treated with invasive procedures and geriatric 
population. More clinically ill patients with previously incurable 
diseases (Leukemias, renal, hepatic fdures, cystic fibrosis) survived 
due to invasive diagnostic and therapeutic procedures: This logic 
increase of nosocomial bacterial (ventillatory pneumonia, catheter 
related bacterias), wal (BMT-related late d infections) fungal 
(hematologic neoplasias) or parasitic (AIDS-related) nosocormal in- 
fections appeared. In contrast to &IS, socio-economic situation in 
health care in Central/Eastern Europe (CEE) until 1990 was not 
affected with new expensive medical technologies and majority of 
nosocomial infections appeared after major or trauma surgery and in 
neonatal intensive care medicine. After political changes and open- 
ing borders, medical technology improved communications: e.g. no 
of BMT centers in CEE increased h m  9 to 85 (in 1995) and 
no of dialysis increased h m  approx 200 to more than 1500. Also 
the number of patients with liver transplants increped tenfold and 
lung transplants fivefold in comparison to 1990. In etiology, increase 
of grampositive bacteremia and fungi was detected. However, In- 
cidence of VR enterococci is still 0-2% in comparison to Western 
Europe, but resistance in staphylococci to oxacillin and Ps. aerugi- 
nosa to aminoglycosides is higher than in Western Europe. 
Nosocomial Infections in HIV Patients 
E. Bouza. E 
No absaact available 
Multi-R strains in hospitals: should we control 
them or live with them? 
B. Regnier. Bichat-Claude Hospital, Paris, France 
Although the threat of antimicrobial resistance has been repeatedly ad- 
dressed, it is obvious that epidemiological trends reported &om many 
countries reflect a poor implementation of the control measures. In 
fact, some authorities still question the relevance of such programs. It 
is therefore necessary to better delineate the impact ofmulti-R strains 
in hospitals and justify these expensive and time-consuming strategies. 
Several effects of a high rate antimicrobial resistance are documented 
such as an increased use of newhroad spectrum antibiotics. Ths, 
in turn, results in the emergence of new mechanisms of resistance 
and high costs. Transfer or readmission of colonized patients results 
in the Musion of R-strains to other hospitals or care-facilities and 
occasionally to other countries. F d y ,  hospital costs and workload 
ofhealth care workers are increased as a result ofisolation precautions. 
However, it is likely that some other impact of R-strains have been 
overlooked such as the relationship between antimicrobial-resistance 
and the severity and the incidence of nosocomial infections (NI). Of 
particular interest are several evidence strongly suggesting that high 
prevalence of R-strains could result in an increased the incidence 
of NI. They include: 1) epidemiological reports whch have docu- 
mented a rise in NI-rate following the introduction of R-strains in 
hospitals, 2) numerous clusters of R-strains-related NI superimposing 
to baseline attack rate, 3) some large prevalence studies have found 
a close association between NI and antimicrobial resistance rates 
throughout hospitals and countries, 4) despite susceptible strains are 
not less virulent it is striking that the R/S/ ratio is much more higher 
among NI isolates as compared with patients flora, 5) the occurrence 
of R-strains has been often incriminated in the failure of previously 
effective prophylactic regimen (surgery, SDD ...), 6) the probability of 
infection following colonization is higher for R-strains as compared 
with S-strains. The most likely explanation for these observations 
is that antibiotics given to 3 W O %  of hospitalized patients (6MO% 
in ICUs) leads to an untoward prophylaxis of NI only in patients 
not colonized with R-strains. In conclusion a high prevalence of 
multi-R-strains is probably and independent risk factor for NI. This, 
in addition to the non-quality sigdcation of cross colonization 
with R-strains, strongly supports the vigorous implementation of 
antimicrobial resistance control in hospitals. 
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Treatment of HIV Seroconversion 
L. Perrin, G. Schockmel, S. Yerly, B. Hirschel. Division ofhfectiouc 
Diseases, Geneva University Hospital, Geneva, Switzerland 
There is mounting evidence that clinical, virological and immuno- 
logical events occurring at the time of seroconversion govern the 
subsequent course of the infection. Ths and new data on patho- 
genesis demonstrating that HIV replication is active throughout the 
course of the dection support antiviral therapy starting as soon as 
the infection is detected. 
Several therapeutic trials using combined therapy (2 reverse tran- 
scriptase inhibitors @TI) or 2 RTI in combination with antiprotease), 
have induced in a majority of patients enrolled, a drop of viremia to 
undetectable levels (less than 200 HIV-1 RNA copiedml). By us- 
ing a mo&ed assay for viremia with a detection limit of around 10 
copiedml, we have shown that a number of patients had viremia lev- 
els between 10 and 200 copies/ml, 6 to 15 months after initiation of 
treatment. However, lymphoid organs are the main site ofviral storage 
and replication. Thus, analysis of lymph node biopsies might provide 
more in depth information on treatment efficacy. 
In this context, preliminary data in patients with viremia lower 
than 10 HIV RNA copies/ml shows an absence of viral deposits and 
no evidence of viral replication in lymph nodes. In contrast, patients 
with residual low viremia levels have incomplete clearance of viral 
deposits and low viral replication in lymph nodes. 
Concomitant analysis of viral load in blood and lymph nodes 
might help to evaluate therapeutic efficacy and to define guidehes 
for treatment (interruption of treatment, change in treatment or 
introduction of a simplified long-term maintenance therapy). 
15911 Which drugs for which patients? 
AJ. Pinching. St. Bartholomew’s and fhe Royal London School .f 
Medicine and Dentistry, London, UK 
Over the past year, there has been a radical change in the approach to 
anti-retroviral therapy in HIV-infected patients. Several new agents 
have become available. Many clinical trials have indicated that com- 
bination therapy with three or more agents will more profoundly 
and durably suppress viral replication. Viral load measures using PCR 
